Grants and Contributions:
Title:
UKRI Biomanufacturing - 10101506 FF UB Stem Cell Proj - Utilization of Sustainable Growth Factors for the Automated Manufacture of Cellular Therapeutics
Agreement Number:
1015076
Agreement Value:
$821,314.00
Agreement Date:
Mar 1, 2024 - Aug 31, 2025
Description:
In this project, Future Fields (FF) will use cutting-edge genome editing techniques to engineer Drosophila melanogaster, where the stable stocks will be used to produce high functioning humanized growth factors required for our UK counterpart, Unicorn Biotechnologies (UB). UB will use these high functioning proteins within their novel automated and continuous cell passaging and scale-up system.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Edmonton, Alberta, CA T5H 0L5
Reference Number:
172-2023-2024-Q4-1015076
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
769272485
Recipient Type:
For-profit organization
Recipient's Legal Name:
Future Fields Cellular Agriculture and Research LTD.
Federal Riding Name:
Edmonton Centre
Federal Riding Number:
48014
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171